NJ Judge Won't Toss FCA Suit Over J&J Unit's Cancer Drug
A New Jersey federal judge refused to release a Johnson & Johnson pharmaceutical unit and affiliates from a patent attorney's False Claims Act lawsuit over the prostate cancer treatment Zytiga, reasoning...To view the full article, register now.
Already a subscriber? Click here to view full article